Sarconesin II

General Information


DRACP ID  DRACP03834

Peptide Name   Sarconesin II

Sequence  VALTGLTVAEYFR

Sequence Length  13

UniProt ID  A0A0L0BSV2 

PubChem CID  Not available

Origin  Animalia

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C67H106N16O19

Absent amino acids  CDHIKMNPQSW

Common amino acids  ALTV

Mass  165390

Pl  6.4

Basic residues  1

Acidic residues  1

Hydrophobic residues  7

Net charge  0

Boman Index  -155

Hydrophobicity  86.92

Aliphatic Index  120

Half Life 
  Mammalian: 20 hour
  Yeast: 30 min
  E.coli: >10 hour

Extinction Coefficient cystines  1490

Absorbance 280nm  124.17

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31159162

Title  Sarconesin II, a New Antimicrobial Peptide Isolated from Sarconesiopsis magellanica Excretions and Secretions

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  13431

DRACP is developed by Dr.Zheng's team.